• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0026840779
Device Problems Material Rupture (1546); Adverse Event Without Identified Device or Use Problem (2993); Activation Failure (3270)
Patient Problems Obstruction/Occlusion (2422); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/19/2021
Event Type  Injury  
Event Description
It was reported that a balloon rupture occurred.A 4.00 x 24mm synergy xd drug eluting stent balloon was selected for treatment of an infarction, but while attempting to place the stent, the balloon ruptured.It was noted that the balloon remained in it, and the stent did not deploy.It was noted that there was major risk of cardiac arrest due to obstruction of the artery by the balloon.No further patient complications were reported in relation to this event.
 
Event Description
It was reported that a balloon rupture occurred.A 4.00 x 24mm synergy xd drug eluting stent balloon was selected for treatment of an infarction, but while attempting to place the stent, the balloon ruptured.It was noted that the balloon remained in it, and the stent did not deploy.It was noted that there was major risk of cardiac arrest due to obstruction of the artery by the balloon.No further patient complications were reported in relation to this event.It was further reported that after the balloon rupture a second physician came to help the first physician with the removal of the balloon from the stent.This was during a stemi procedure the target lesion was located in a non calcified and non tortuous circumflex (cx).A 15mm x 2.5 emerge balloon was advanced to predilate the lesion, and crossed the lesion successfully.It was noted that the 4.00 x 24mm synergy xd stent was deployed, but not completely.The stent balloon was inflated at 10 atmospheres, but the pressure of the inflation device could not be maintained due to the perforated balloon.It was noted that blood was observed in the inflation device following the balloon rupture.Several attempts were performed to remove the balloon, but it remained stuck to the stent.It was noted that during this time, the patient was doing well, without any signs of pain because there was blood flow in the artery.After 20 minutes, and several attempts, the balloon was removed the stent.There were no patient complications resulted in relation to this event.The patient was reported to be fine without consequences.
 
Event Description
It was reported that a balloon rupture occurred.A 4.00 x 24mm synergy xd drug eluting stent balloon was selected for treatment of an infarction, but while attempting to place the stent, the balloon ruptured.It was noted that the balloon remained in it, and the stent did not deploy.It was noted that there was major risk of cardiac arrest due to obstruction of the artery by the balloon.No further patient complications were reported in relation to this event.It was further reported that after the balloon rupture a second physician came to help the first physician with the removal of the balloon from the stent.This was during a stemi procedure the target lesion was located in a non calcified and non tortuous circumflex (cx).A 15mm x 2.5 emerge balloon was advanced to predilate the lesion, and crossed the lesion successfully.It was noted that the 4.00 x 24mm synergy xd stent was deployed, but not completely.The stent balloon was inflated at 10 atmospheres, but the pressure of the inflation device could not be maintained due to the perforated balloon.It was noted that blood was observed in the inflation device following the balloon rupture.Several attempts were performed to remove the balloon, but it remained stuck to the stent.It was noted that during this time, the patient was doing well, without any signs of pain because there was blood flow in the artery.After 20 minutes, and several attempts, the balloon was removed the stent.There were no patient complications resulted in relation to this event.The patient was reported to be fine without consequences.
 
Manufacturer Narrative
Device evaluated by mfr: a 4.00 x 24mm synergy xd stent delivery system (sds) was returned for analysis.The device was returned with no stent attached.The crimped stent od (outer diameter) was measured and was within maximum crimped stent profile measurement.The balloon returned in a deflated state.Solidified blood like media was visible inside the balloon.Microscopic examination of the balloon material identified a hole at approximately 3mm distal from the proximal marker band.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube identified a hypotube break located approximately 71.9cm distal to the distal strain relief, as well as multiple hypotube kinks at several locations along the hypotube shaft.A visual examination of the outer and inner lumen and mid shaft section found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12408045
MDR Text Key269470008
Report Number2134265-2021-11111
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Pharmacist
Type of Report Initial,Followup,Followup
Report Date 02/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/09/2023
Device Lot Number0026840779
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/11/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/09/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-